Evidence map›Paper›PMID 27273599›Full record

ArticleMolecular nutrition & food research2016

Long-chain monounsaturated fatty acid-rich fish oil attenuates the development of atherosclerosis in mouse models.

Zhi-Hong Yang, Masahiro Bando, Toshihiro Sakurai, Ye Chen, Beatrice Emma-Okon, Bree Wilhite, Daiju Fukuda, Boris Vaisman, Milton Pryor, Yoshiyuki Wakabayashi and 9 more

Open access · greenAbstract read
In one paragraph

Article in Molecular nutrition & food research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 2 countries.

Zhi-Hong YangLipoprotein Metabolism Section, Cardio-Pulmonary Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD, USA. zhihong.yang@nih.gov.
Masahiro BandoInstitute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Toshihiro SakuraiLipoprotein Metabolism Section, Cardio-Pulmonary Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD, USA.
Ye ChenSystems Biology Center, NHLBI, NIH, Bethesda, MD, USA.
Beatrice Emma-OkonLipoprotein Metabolism Section, Cardio-Pulmonary Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD, USA.
Bree WilhiteSection on Nutritional Neurosciences, Laboratory of Membrane Biochemistry and Biophysics, National Institute on Alcohol Abuse and Alcoholism, NIH, Bethesda, MD, USA.
Daiju FukudaInstitute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Boris VaismanLipoprotein Metabolism Section, Cardio-Pulmonary Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD, USA.
Milton PryorLipoprotein Metabolism Section, Cardio-Pulmonary Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD, USA.
Yoshiyuki WakabayashiDNA Sequencing Core, NHLBI, NIH, Bethesda, MD, USA.
Maureen SampsonClinical Center, Department of Laboratory Medicine, NIH, Bethesda, MD, USA.
Zu-Xi YuPathology Core, NHLBI, NIH, Bethesda, MD, USA.
Akiko SakuraiLipoprotein Metabolism Section, Cardio-Pulmonary Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD, USA.
Abdalrahman ZarzourLipoprotein Metabolism Section, Cardio-Pulmonary Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD, USA.
Hiroko MiyaharaCentral Research Laboratory, Nippon Suisan Kaisha, Tokyo, Japan.
Jiro TakeoCentral Research Laboratory, Nippon Suisan Kaisha, Tokyo, Japan.
Hiroshi SakaueInstitute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Masataka SataInstitute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Alan T RemaleyLipoprotein Metabolism Section, Cardio-Pulmonary Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD, USA.
National Heart Lung and Blood Institute · USNational Institutes of Health · USTokushima University · JPNippon Suisan Kaisha (Japan) · JPZero to Three · USNational Institute on Alcohol Abuse and Alcoholism · USNational Institutes of Health Clinical Center · US

Funding

NHLBI Animal Program DivisionZIGHL006020 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI CLARK, TANNIA · 2009 to 2025
$47.3M
Use Of Animal Models To Study Lipid Genes That Modulate AtherosclerosisZIAHL002058 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI REMALEY, ALAN THOMAS · 2009 to 2019
$14.3M
Pathology CoreZICHL005904 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI YU, ZU XI · 2010 to 2023
$11.6M
Systems Biology CoreZIAHL006192 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI WANG, XUJING · 2014 to 2016
$4.6M
Intramural NIH HHS Z99 HL999999
6 · The paper itself

Abstract

scopeFish oil-derived long-chain monounsaturated fatty acids (LCMUFA) containing chain lengths longer than 18 were previously shown to improve cardiovascular disease risk factors in mice. However, it is not known if LCMUFA also exerts anti-atherogenic effects. The main objective of the present study was to investigate the effect of LCMUFA on the development of atherosclerosis in mouse models. METHODS AND

resultsLDLR-KO mice were fed Western diet supplemented with 2% (w/w) of either LCMUFA concentrate, olive oil, or not (control) for 12 wk. LCMUFA, but not olive oil, significantly suppressed the development of atherosclerotic lesions and several plasma inflammatory cytokine levels, although there were no major differences in plasma lipids between the three groups. At higher doses 5% (w/w) LCMUFA supplementation was observed to reduce pro-atherogenic plasma lipoproteins and to also reduce atherosclerosis in ApoE-KO mice fed a Western diet. RNA sequencing and subsequent qPCR analyses revealed that LCMUFA upregulated PPAR signaling pathways in liver. In cell culture studies, apoB-depleted plasma from LDLR-K mice fed LCMUFA showed greater cholesterol efflux from macrophage-like THP-1 cells and ABCA1-overexpressing BHK cells.

conclusionOur research showed for the first time that LCMUFA consumption protects against diet-induced atherosclerosis, possibly by upregulating the PPAR signaling pathway.

Indexed as

AnimalsApolipoproteins EAtherosclerosisCell LineCholesterolCytokinesDisease Models, AnimalFatty AcidsFatty Acids, MonounsaturatedFish OilsHumansLipidsLiverMacrophagesMice, KnockoutReceptors, LDLApolipoproteins ECholesterolCytokinesFatty AcidsFatty Acids, MonounsaturatedFish OilsLipidsReceptors, LDLAtherosclerosisCholesterol effluxInflammationLong-chain monounsaturated fatty acidsPPAR signaling pathway

Identifiers

PMID27273599
PMCPMC5056854
OpenAlexW2410555335

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.